학술논문
129P Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort
Document Type
Abstract
Author
Source
In Annals of Oncology May 2020 31 Supplement 2:S59-S59
Subject
Language
ISSN
0923-7534